Sam Faulkner
Newcastle, NSW 2308, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Monitoring glioblastoma extracellular vesicle evolution using a nanodiagnostic platform to detect glioma stem cells driving recurrent disease.
Journal: Science advances
Published: January 30, 2026
CCL2/CCR2 Expression in Locally Advanced Prostate Cancer and Patient Long-Term Outcome: 10-Year Results from the TROG 03.04 RADAR Trial.
Journal: Cancers
Published: July 05, 2024
Vasculogenic Mimicry Occurs at Low Levels in Primary and Recurrent Glioblastoma.
Journal: Cancers
Published: July 06, 2023
The Membrane Protein Sortilin Is a Potential Biomarker and Target for Glioblastoma.
Journal: Cancers
Published: March 28, 2023
Targeting XBP1 mRNA splicing sensitizes glioblastoma to chemotherapy.
Journal: FASEB bioAdvances
Published: December 22, 2022
ProNGF Expression and Targeting in Glioblastoma Multiforme.
Journal: International journal of molecular sciences
Published: November 13, 2022
Expression of NGF/proNGF and Their Receptors TrkA, p75NTR and Sortilin in Melanoma.
Journal: International journal of molecular sciences
Published: March 30, 2022
Proteome and secretome analysis of pancreatic cancer cells.
Journal: Proteomics
Published: November 03, 2021
iTRAQ-based quantitative proteomics analysis of Sprague-Dawley rats liver reveals perfluorooctanoic acid-induced lipid metabolism and urea cycle dysfunction.
Journal: Toxicology letters
Published: July 24, 2021
ELISA-based quantification of neurotrophic growth factors in urine from prostate cancer patients.
Journal: FASEB bioAdvances
Published: July 12, 2021
Low tumour-infiltrating lymphocyte density in primary and recurrent glioblastoma.
Journal: Oncotarget
Published: July 01, 2021
Interactions of perfluorooctanoic acid with acyl-CoA thioesterase 1 (Acot1).
Journal: Comparative biochemistry and physiology. Toxicology & pharmacology : CBP
Published: June 24, 2021
Last Updated: 09/26/2026